Sex Steroid Hormones in Diabetes-Induced Sexual Dysfunction: Focus on the Female Gender

Abstract

Introduction Diabetes is associated with gender-specific changes in sex steroid hormones. However, the mechanisms responsible for these associations as well as the link to sexual dysfunction are not well understood. Aim To discuss key clinical and laboratory findings linking diabetes, sex steroid hormones, and sexual dysfunction, with particular focus on the female gender. Methods A comprehensive literature review was conducted using the PubMed database. Search terms were used in appropriate combinations, including diabetes, insulin, insulin sensitivity, androgen, estrogen, sexual function, women, men, estrogen receptor, and androgen receptor. Over 400 citations were selected, based on topical relevance, and examined for study methodology and major findings. Main Outcome Measures Data from peer-reviewed publications. Results Imbalances in sex steroid hormone levels are strongly associated with diabetes and this may negatively impact upon sexual function. Although numerous factors are likely to contribute to the development of diabetes and its complications, the role of sex steroid hormones must be acknowledged. Conclusions Research related to diabetic women and sexual dysfunction is severely lacking. Identifying underlying causes for a given hormonal imbalance in diabetic patients, as well as determination of genetic and age-dependent factors, will become important in identifying the subpopulations in which hormonal replacement regimens will be most effective. Investigation into treating diabetic patients with adjunct hormonal therapies or steroid hormone receptor modulators holds much promise.

Gender Bias in Gastroparesis: Is Nitric Oxide the Answer?

“…We and others have reported that circulating estrogen levels are higher in female compared to male rats [47] and that diabetes induction decreases circulating estrogen and progesterone and their receptors in various tissues in both women and in female rats [8]. Our findings [48] correlate with those of Shah et al [6] in which they demonstrated that E 2 , but not P 4 , may be responsible for increased gastric nNOS expression and nitrergic relaxation.…”

“…In addition, P 4 treatment decreases the resting tension of fundus and inhibits the mean contractile amplitude of gastric antrum as well as the motility index of pylorus in rats [7]. It is clear that diabetes induction decreases both circulating E 2 and P 4 levels in females [8]. Collectively, the above studies suggest that in general gastric motility is slower (delayed gastric emptying but not gastroparesis) in women compared to men and this was perhaps due to elevated levels of sex steroid hormones and NO.…”

Type 2 diabetes and cardiovascular disease in women

“…In women with diabetes or polycystic ovary syndrome, there is a hormonal imbalance in androgen and oestrogen levels, and sex hormones appear to influence glucose control in women with diabetes [64]. Promising experimental research results, including the positive effects of oestrogen on endothelial function [65] and the obvious clinical relief of typical menopausal symptoms, were the basis of previously extensive use of sex-hormone-replacement therapy in postmenopausal women.…”

Improvement in Sexual Functioning in Patients With Type 2 Diabetes and Depression Treated With Bupropion

“…Diabetes may negatively influence SF though multiple pathophysiologic pathways, that is, vascular, neurologic, and hormonal effects (7–10). Hyperglycemia also impairs SF and may have been a factor in this sample (mean A1C >8%) (11).…”